Does MEGLUMINE Cause Hypercholesterolaemia? 232 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 232 reports of Hypercholesterolaemia have been filed in association with MEGLUMINE. This represents 39.7% of all adverse event reports for MEGLUMINE.
232
Reports of Hypercholesterolaemia with MEGLUMINE
39.7%
of all MEGLUMINE reports
232
Deaths
225
Hospitalizations
How Dangerous Is Hypercholesterolaemia From MEGLUMINE?
Of the 232 reports, 232 (100.0%) resulted in death, 225 (97.0%) required hospitalization, and 230 (99.1%) were considered life-threatening.
Is Hypercholesterolaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MEGLUMINE. However, 232 reports have been filed with the FAERS database.
What Other Side Effects Does MEGLUMINE Cause?
Off label use (389)
Maternal exposure during pregnancy (300)
Joint swelling (294)
Pemphigus (289)
Glossodynia (288)
Inflammation (285)
Pain (284)
General physical health deterioration (283)
Folliculitis (282)
Hypertension (282)
What Other Drugs Cause Hypercholesterolaemia?
ALENDRONATE (1,607)
METHOTREXATE (1,547)
TOCILIZUMAB (1,483)
ADALIMUMAB (1,479)
ABATACEPT (1,410)
RITUXIMAB (1,389)
PREDNISONE (1,377)
INFLIXIMAB (1,338)
DICLOFENAC (1,331)
LEFLUNOMIDE (1,322)
Which MEGLUMINE Alternatives Have Lower Hypercholesterolaemia Risk?
MEGLUMINE vs MELATONIN
MEGLUMINE vs MELOXICAM
MEGLUMINE vs MELPERONE
MEGLUMINE vs MELPHALAN
MEGLUMINE vs MEMANTINE